Serological methods for diagnosis of Helicobacter pylori infection and monitoring of eradication therapy.
Several methods can be used to diagnose Helicobacter pylori infection. Invasive methods include detection of the bacterium in gastric biopsy specimens by culture, immunohistochemistry, rapid urease tests, or the polymerase chain reaction. Noninvasive or less invasive detection methods include the urea breath test and serological methods. The urea breath test is based on the detection of 13CO2 or 14CO2 in breath, produced by bacterial urease in the stomach after labelled urea is swallowed. Serological methods are based on the detection of Helicobacter pylori-specific antibodies in serum, saliva, or urine. In this review, the performance and diagnostic value of several serological methods, such as enzyme immunoassay, rapid office-based assays, and Western blot, will be discussed in relation to biopsy-based methods and the urea breath test. In addition, the value of serological assays for monitoring eradication of Helicobacter pylori infection following treatment will be discussed. The diagnostic performance of properly evaluated serological assays is comparable to that of biopsy-based methods and the urea breath test. To monitor eradication of Helicobacter pylori infection following therapy, quantitative enzyme immunoassays can be used, especially in patients with high pretreatment antibody titres.
Herbrink
P
P
Diagnostic Centre SSDZ, Medical Laboratories, Delft, The Netherlands. herbrink@rdgg.nl
van Doorn
L J
LJ
D000907:Antibodies, Bacterial / Q000032:analysis* / Q000097:blood / Q000652:urine; D000942:Antigens, Bacterial / Q000276:immunology; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D016480:Helicobacter pylori / Q000235:genetics / Q000276:immunology*; D006801:Humans; D012698:Serologic Tests
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial